Product
SIM1811-03
2 clinical trials
3 indications
Indication
Advanced Solid TumorIndication
Cutaneous T-cell LymphomaIndication
Cutaneous T-Cell LymphomaClinical trial
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell LymphomaStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
An Open-label, Phase I Trial of SIM1811-03 to Assess the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics in Subjects With Advanced TumorsStatus: Recruiting, Estimated PCD: 2025-06-30